home
tele1
mail1
Asset 1.png

Cytion: Premier Cell Bank for Authentic Human and Animal Cells 

image001-4-1-hyy7zj-316569
  • Cytion: Banca de celule premium pentru celule umane și animale. Cytion își menține reputația de bancă de celule de încredere.
    Cytion, fostul Cell Line Services sunt specializați în celule de înaltă calitate, fără contaminare de la oameni și animale, asigurând un control riguros al calității și autentificare. 
  • Renumite pentru fiabilitate, liniile celulare Cytion sunt alegerea ideală pentru cercetătorii care au nevoie de mostre genetice autentice. Cu Cytion, experimentați ușurința și încrederea în aprovizionarea cu soluții autentice de cultură celulară.

Linii celulare

adrenalglanddiagram
Adrenal gland cell lines
WhatsApp Image 2024-03-16 at 12.37.13
Animal cells (cat cell lines)
mink-186995.jpg
Animal cells (mink cell lines)
aviantreeofl
Avian cell lines
Acute_leukemia-ALL
B lymphoblast cell lines
mhh-es1-(1)_1920x1920
Bone Cancer Cell Lines
Fisheye view of cattle domesticated of the subfamily Bovinae aka cow mammal animal
Bovine cell lines
  • ...Celulele MDBK, prescurtarea de la Madin-Darby Bovine Kidney cells (cunoscute și sub numele de NBL-1), sunt o resursă biologică excepțională derivată din rinichii unui adult Bos taurus aparent sănătos...
  • FBHE Cells
  • MDBK (NBL-1) Cells
Brain-Tumor-Program-Main-Image
Brain cancer cell lines
  • ...Cancerele cerebrale includ tumorile cerebrale primare, care încep în creier și aproape niciodată nu se răspândesc în alte părți ale corpului, și tumorile secundare (sau metastaze), care sunt cauzate de cancere care au început într-o altă parte a corpului...
  • Brain cancer cell lines
mhh-es1-(1)_1920x1920
Breast Cancer Cell Lines
  • .. Celulele MCF7, un element de bază în cercetarea cancerului de sân uman, sunt utilizate pe scară largă ca model in vitro pentru cancerul de sân dependent de hormoni. Originar din țesutul mamar al unei femei albe de 69 de ani cu adenocarcinom metastatic...
  • Breast cancer cell lines
Burkitt lymphoma, touch prep, Wright stain
Burkitt Lymphoma Cell Lines
  • ...Limfomul Burkitt (BL) este un limfom agresiv non-Hodgkin cu celule B. Boala este asociată cu virusul Epstein Barr (EBV), virusul imunodeficienței umane (HIV) și translocațiile cromozomiale care provoacă supraexprimarea oncogenei c-myc...
  • Burkitt Lymphoma Cell Lines
FILE - This photo provided by the U.S. Fish and Wildlife Service shows a gray wolf, April 18, 2008. The collars from two gray wolves sent a mortality signal Dec. 29, 2023. State wildlife officials responded and found three dead wolves, two with collars and one without, the U.S. Fish and Wildlife Service said in a statement. (Gary Kramer/U.S. Fish and Wildlife Service via AP, File)
Canine cell lines
NIH_3T3
Fibroblasts
Human Stomach Anatomy Illustration. 3D render
Gastric cell lines
hacat-(5)
HaCaT cell lines
images
Hamster cell lines
14458-head-and-neck-cancer
Head / neck cancer cell lines
  • ..Linia celulară C643 a fost stabilită dintr-o biopsie cu ac fin a unui carcinom tiroidian anaplazic al unui bărbat de 76 de ani de către Mark și colab. în 1987. Pacientul a murit în 5 luni de la diagnostic...
  • Head and neck cancer cell lines
PSXgfeg9rZtrnvNut7D8uQ_Human_anatomy
Human cell lines
FC-0044-Pooled-Umbilical-Vein-Endothelial-Cells-HUVEC-10x
HUVEC
  • Celulele endoteliale ale venei ombilicale umane (HUVEC) sunt celule primare izolate din vena cordonului ombilical.
  • HUVEC, single donor
AC-16 P1 10x01 190124_ch00_1920x1920
Hybrid cell lines
  • ...Linia celulară AC16, derivată din celule ventriculare umane fuzionate cu fibroblaste  transformate în SV40, prezintă caracteristicile cardiomiocitelor, inclusiv expresia factorilor de transcripție GATA4...
  • AC16 Cardiomyocyte Cell Line
fall-armyworm-adult-Spodoptera-frugiperda.jpg
Insect cell lines
  • ...Celulele Sf9 sunt izolate clonale derivate din linia celulară Spodoptera frugiperda Sf21 (IPLB-Sf-21-AE). Ele sunt utilizate în mod obișnuit în cultura de celule de insecte pentru producerea de proteine ​​recombinate...
  • Sf9 Cells
14501-colorectal-cancer
Intestine cancer cell lines
Kidney-Cancer-800x465
Kidney cancer cell lines
  • ...Cancerul de rinichi se dezvoltă atunci când celulele din rinichi se schimbă și cresc fără control. Persoanele cu cancer de rinichi pot observa dureri de flanc, hipertensiune arterială, sânge în pipi și alte simptome. Tratamentele pentru cancerul de rinichi includ chirurgie, chimioterapie și radioterapie...
  • Kidney cancer cell lines
4365-leukemia
Leukemia cancer cell lines
  • ...Leucemia este un termen larg pentru cancerul celulelor sanguine. Tipul de leucemie depinde de tipul de celulă sanguină care devine cancer și dacă crește rapid sau lent. Leucemia apare cel mai adesea la adulții peste 55 de ani, dar este și cel mai frecvent cancer la copiii sub 15 ani...
  • Leukemia cell lines
  • Nalm-6 Cells
ds00097_-ds00398_-ds00399_-ds00411_im04073_mcdc7_livercancerthu_jpg
Liver cancer cell lines
lung-cancer-tumor-8col
Lung cancer cell lines
  • ...Cancerul pulmonar, cunoscut și sub denumirea de carcinom pulmonar, este o tumoare malignă care debutează în plămâni. Cancerul pulmonar este cauzat de deteriorarea genetică a ADN-ului celulelor din căile respiratorii, adesea cauzată de fumatul de țigări sau de inhalarea de substanțe chimice dăunătoare...
  • Lung cancer cell lines
media-3652
Lymphoma cancer cell lines
A vertical selective focus shot of long-tailed macaque
Monkey cell lines
Mouse_white_background-removebg-preview
Mouse cell lines
  • ...Celulele MC38 sunt o linie celulară murină utilizată pe scară largă ca model pentru cercetarea carcinomului colorectal. Originar dintr-un adenocarcinom de colon la un șoarece C57BL/6...
  • Mouse cell lines
Created for the National Cancer Institute, http://www.cancer.gov
Myeloma cell lines
  • ...Mielomul este un tip de cancer care se dezvoltă din celulele plasmatice din măduva osoasă. Mielomul este uneori numit mielom multiplu deoarece afectează mai mult de o parte a corpului...
  • RPMI 8226 Cells
  • MOLP-8 Cells
  • U266 Cells
GetImage
Neuroblastoma cell lines
640px-Opossum_2
Opposum cell lines
icon-zelle_1920x1920
Oral cell lines
636528
Pancreas cancer cell lines
  • ...Cancerul pancreatic este un tip de cancer care se formează în țesuturile pancreasului. Fumatul și istoricul de sănătate pot afecta riscul de cancer pancreatic. Semnele și simptomele cancerului pancreatic includ icter, durere și scădere în greutate. Cancerul pancreatic este dificil de diagnosticat precoce...
  • Pancreas cancer cell lines
pig-young-closeup_3x4
Pig cell lines
636528
Pancreas cancer cell lines
  • ...Cancerul pancreatic este un tip de cancer care se formează în țesuturile pancreasului. Fumatul și istoricul de sănătate pot afecta riscul de cancer pancreatic. Semnele și simptomele cancerului pancreatic includ icter, durere și scădere în greutate. Cancerul pancreatic este dificil de diagnosticat precoce...
  • Pancreas cancer cell lines
prostate
Prostate cancer cell lines
rdd-logo-transparent
Rare disease cell lines
220px-Rattus_norvegicus_1
Rat Cell Lines
HK-CRISPR-Nup188-mEGFP-(1)_400x400
Reporter labeled cells
  • ...Liniile celulare marcate cu reporter sunt instrumente de cercetare neprețuite pentru studierea expresiei genelor și pentru screeningul liniilor celulare. Unele dintre cele mai frecvent utilizate sisteme reporter sunt cele care induc un fenotip identificabil vizual, cum ar fi emisia de lumină fluorescentă sau luminiscentă sau producerea unui produs pigmentat...
  • Reporter labeled cells
gynecological_Uterus-Cancer-Women
Reproductive system cancer cells
  • ...Când cancerul începe în organele reproducătoare ale unei femei, se numește cancer ginecologic. Cele cinci tipuri principale de cancer ginecologic sunt: ​​cervical, ovarian, uterin, vaginal și vulvar. (Un al șaselea tip de cancer ginecologic este cancerul de trompe uterine foarte rar.)...
  • Reproductive system cancer cell lines
Layers-Of-Skin_1024x1024
Skin cancer cell lines
  • ...Linia celulară ARPE-19 este o linie celulară de epitelii pigmentare retiniene (RPE) imortalizată spontan, derivată de la un bărbat de 19 ani. Celulele ARPE-19 prezintă proprietăți structurale și funcționale care sunt caracteristice celulelor RPE in vivo...
  • Skin cancer cell lines
63a1e82cd2032e28395915c3_Mesenchymal stem cell copy
Stem cells 
Transformed-cells-employ-different-strategies-to-compensate-for-or-circumvent-the
Transformed cell lines
bladder
Urinary bladder cancer cell lines
  • ...Când cancerul începe în organele reproducătoare ale unei femei, se numește cancer ginecologic. Cele cinci tipuri principale de cancer ginecologic sunt: ​​cervical, ovarian, uterin, vaginal și vulvar. (Un al șaselea tip de cancer ginecologic este cancerul de trompe uterine foarte rar.)...
  • Urinary bladder cancer cell lines

Medii si reactivi

1676-maintain-cell-bank
Cell banking
Accutase,100ml_1920x1920
Cell detachment
  • Accutase
Visualization of a chromosomes, 3d rendering, DNA, Genetics, illustration_1280x720
Cell line authentication
DMEM high glucose basic_1920x1920
Cell culture media 
  • DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate
  • DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3
  • Ham's F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3
  • IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3
  • McCoys 5A medium (modified), w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3
  • Ham's F12 Medium, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.176 g/L NaHCO3
  • EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA
  • Medium 199, w: 2.7 mM stable Glutamine, w: 2.2 g/L NaHCO3, w: EBSS
  • RPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3
  • RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3
  • NCI-H295R Cell Growth Medium
  • Endothelial Cell Growth Medium
CM-ACF freeze medium_1920x1920
Cryopreservation media
  • Freeze Medium CM-1 - 100 ml
  • Freeze Medium CM-1 - 50 ml
  • Freeze medium CM-ACF - serum free - 500 ml
  • Freeze medium CM-ACF - serum free - 50 ml
  • Freeze medium CM-ACF - serum free - 100 ml
  • Freeze Medium CM-1 - 500 ml
rt-112-(3)_1920x1920
DNA
  • RT-112 genomic DNA - 5 microgram
  • 5637 genomic DNA - 5 microgram
  • T24 genomic DNA - 5 microgram
  • HEK293 genomic DNA - 5 microgram
  • HeLa genomic DNA - 5 microgram

Lista Produse Cytion (Cell Line Services)

nameproductNumbercategoriesorganismtissuediseasecultureMedium
MDCC-MSB1 Cells601413 Avian cell linesChickenMarek diseaseRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LMH Cells601411 Avian cell linesChickenLiverHepatocellular carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
UMNSAH/DF-1 Cells305016 Avian cell linesChickenEmbryoDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MHH-ES1 Cells300136 Bone cancer cell linesHumanBoneEwings SarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SW-1353 Cells300440 Bone cancer cell linesHumanBone, right humerusChondrosarcoma (Grade II)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
KHOS-312H Cells300447 Bone cancer cell linesHumanBoneOsteosarcomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
KHOS-NP Cells300235 Bone cancer cell linesHumanBoneOsteosarcomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
MG-63 Cells300441 Bone cancer cell linesHumanBoneOsteosarcomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SJSA-1 Cells305096 Bone cancer cell linesHumanBoneOsteosarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RD-ES Cells300410 Bone cancer cell linesHumanBoneEwings SarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
L Wnt-3A Cells305184 Bone cancer cell linesMouseSubcutaneous connective tissue, areolar and adiposeDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS Cells300364 Bone cancer cell linesHumanBone, tibiaOsteosarcomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SK-ES-1 Cells300435 Bone cancer cell linesHumanBoneEwings SarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
CADO-ES1 Cells300127 Bone cancer cell linesHumanBoneEwings SarcomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HS-729 Cells300443 Bone cancer cell linesHumanBoneEmbryonal rhabdomyosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
A673 Cells300454 Bone cancer cell linesHumanBoneEwings SarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
KHOS-240S Cells300433 Bone cancer cell linesHumanBoneOsteosarcomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SaOS-2 Cells300331 Bone cancer cell linesHumanBoneOsteosarcomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
MNNG-HOS (CL #5) Cells300289 Bone cancer cell linesHumanBoneOsteosarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HOS Cells300449 Bone cancer cell linesHumanBoneOsteosarcomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROG36 Cells300939 Brain cancer cell linesHumanBrain, R, parietalGlioblastoma (grade III)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG06 Cells300933 Brain cancer cell linesHumanBrain, L, frontalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SK-N-MC Cells300340 Brain cancer cell linesHumanNeuroectodermalAskins tumorEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROG15 Cells300937 Brain cancer cell linesHumanBrain, R, parietalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG17 T1 M1 Cells300875 Brain cancer cell linesHumanBrainGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
U-251 MG Cells300385 Brain cancer cell linesHumanBrainAstrocytomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U87MG Cells300367 Brain cancer cell linesHumanBrainGlioblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
U-138 MG Cells300363 Brain cancer cell linesHumanBrainAstrocytomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HROG10 Cells300935 Brain cancer cell linesHumanBrain, R, temporalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG02 Cells300931 Brain cancer cell linesHumanBrain, R, parietooccipitalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCH421K Cells300118 Brain cancer cell linesHumanBrainGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG33 Cells300877 Brain cancer cell linesHumanBrain, L, occipitotemporalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG07 Cells300934 Brain cancer cell linesHumanBrain, R, temporoparietalRelapsed Glioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG12 T0 M1 Cells300882 Brain cancer cell linesHumanBrainGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG17 Cells300938 Brain cancer cell linesHumanBrain, L, parietooccipital, relapsed tumorGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HS-683 Cells300213 Brain cancer cell linesHumanBrainOligodendrogliomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U-343 MG Cells300365 Brain cancer cell linesHumanBrainGlioblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
A172 Cells300108 Brain cancer cell linesHumanBrainGlioblastomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U-118 MG Cells300362 Brain cancer cell linesHumanBrainAstrocytomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Daoy Cells305053 Brain cancer cell linesHumanBrain, cerebellumMedulloblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROG63 Cells300881 Brain cancer cell linesHumanBrain, L, temporalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HBL-52 Cells300188 Brain cancer cell linesHumanBrainMeningioma, benign cellsDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
CCF-STTG1 Cells300388 Brain cancer cell linesHumanBrainAstrocytoma, grade IVRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LN229 Cells305043 Brain cancer cell linesHumanBrain, right frontal parieto-occipital cortexGlioblastomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HROG13 Cells300936 Brain cancer cell linesHumanBrain, R, temporalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
T98G Cells305030 Brain cancer cell linesHumanBrainGlioblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROG06 T0 M2 Cells300883 Brain cancer cell linesHumanBrainGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG05 Cells300940 Brain cancer cell linesHumanBrain, L, temporalRelapsed Glioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCH690 Cells300120 Brain cancer cell linesHumanBrainGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG24 Cells300876 Brain cancer cell linesHumanBrain, L, occipitalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
D283Med Cells300330 Brain cancer cell linesHumanBrainMedulloblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROG33 T0 M1 Cells300878 Brain cancer cell linesHumanBrainGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROG04 Cells300932 Brain cancer cell linesHumanBrain, R, frontalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
H4 Cells300184 Brain cancer cell linesHumanBrainNeurogliomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HMC3 Cells300102 Brain cancer cell linesHumanFetal brainDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
D341Med Cells305136 Brain cancer cell linesHumanBrain, cerebellumMedulloblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROG59 Cells300880 Brain cancer cell linesHumanBrain, R, parietooccipitalGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SF126 Cells300608 Brain cancer cell linesHumanBrain, left frontal lobeGlioblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROG38 Cells300879 Brain cancer cell linesHumanBrain, R, parietooccipitalGlioblastoma (grade IV)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCH612300121 Brain cancer cell linesHumanBrainAnaplastic oligodendroglioma, WHO grade III, IDH1 mutant (R132H)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCH644 Cells300124 Brain cancer cell linesHumanBrainGlioblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
T406 Cells300361 Brain cancer cell lines | Human cellsHumanBrainGlioblastomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MCF-7 Cells300273 Breast cancer cell linesHumanBreastAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HCC1937 Cells305064 Breast cancer cell linesHumanMammary gland, breast, ductBreast ductal carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BT-474 Cells300131 Breast cancer cell linesHumanBreast, mammary glandInvasive ductal carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
T-47D Cells300353 Breast cancer cell linesHumanBreastInvasive ductal carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
DU4475 Cells300371 Breast cancer cell linesHumanBreastBreast carcinomaRPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3 (Cytion article number 820702a)
BT-549 Cells300132 Breast cancer cell linesHumanBreast, mammary glandInvasive ductal carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Alab Cells300280 Breast cancer cell linesHumanBreastAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HBL-100 Cells300178 Breast cancer cell linesHumanBreastCarcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
Colo-824 Cells300463 Breast cancer cell linesHumanBreast, mammary glandSquamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SUM149PT Cells300609 Breast cancer cell linesHumanBreastBreast inflammatory carcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
MX-1 Cells300296 Breast cancer cell linesHumanBreastAdenocarcinoma, Infiltrating duct carcinoma (IDC)DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Hs 578T Cells305089 Breast cancer cell linesHumanMammary gland, breastInvasive breast carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MA-CLS-2 Cells300271 Breast cancer cell linesHumanBreastDuctal carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SK-BR-3 Cells300333 Breast cancer cell linesHumanBreast, mammary glandInvasive ductal carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
BT-20 Cells300130 Breast cancer cell linesHumanBreast, mammary glandInvasive ductal carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
ZR-75-1 Cells300163 Breast cancer cell linesHumanBreastCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HCC1806 Cells300467 Breast cancer cell linesHumanBreast, mammary glandBreast squamous cell carcinoma, acantholytic variantRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SUM159PT Cells305116 Breast cancer cell linesHumanBreastBreast pleomorphic carcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
MRC-9 Cells300394 Human cellsHumanFetal lungEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HFL1 Cells305065 Human cellsHumanLungHams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
MRC-5 Cells300395 Human cellsHumanLungEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
EA.hy926 Cells305034 Human cells | Hybrid cell linesHumanUmbilical vein, vascular endotheliumDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MCF 10A Cells305026 Human cells | Spontaneously immortalized cell linesHumanMammary gland, breastMEGM (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
LX-2 Cells305039 Human cells | Transformed cell linesHumanLiverDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
hFOB 1.19 Cells305069 Human cells | Transformed cell linesHumanBoneDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
WPMY-1 Cells305083 Human cells | Transformed cell linesHumanProstate, stromaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-2 Cells305021 Human cells | Transformed cell linesHumanKidney, cortex, proximal tubuleDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
K562 Cells300224 Leukemia cell linesHumanBone marrowChronic myeloid leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
M-07e Cells305105 Leukemia cell linesHumanPeripheral bloodChildhood acute megakaryoblastic leukemiaIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
THP-1 Cells300356 Leukemia cell linesHumanThe tissue of origin is peripheral bloodLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NB-4 Cells300299 Leukemia cell linesHumanBone marrowAcute promyelocytic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HL-60 Cells300209 Leukemia cell linesHumanBloodAcute promyelocytic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
TF-1 Cells300434 Leukemia cell linesHumanBone marrowErythroleukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
U937 Cells300368 Leukemia cell linesHumanLymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HEL 92.1.7300462 Leukemia cell linesHumanBone marrowErythroleukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CCRF-CEM Cells300147 Leukemia cell linesHumanPeripheral bloodLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Jurkat E6.1 Cells300223 Leukemia cell linesHumanBloodAcute T cell leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
KG-1a Cells300234 Leukemia cell linesHumanBone marrowAcute myelogenous leukemiaIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
REH Cells300320 Leukemia cell linesHumanPeripheral bloodAcute lymphoblastic leukemia (ALL)RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CESS Cells300262 Leukemia cell linesHumanPeripheral bloodAcute myeloid leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MOLT-3 Cells300116 Leukemia cell linesHumanPeripheral bloodAcute lymphoblastic leukemia (ALL)RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LP-1 Cells300321 Leukemia cell linesHumanPeripheral bloodMultiple myelomaIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
CEM/C1 Cells305103 Leukemia cell linesHumanPeripheral bloodT-cell acute lymphoblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HAL-01 Cells305140 Leukemia cell linesHumanB Cell Precursor LeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SKW-3 Cells300343 Leukemia cell linesHumanHematopoieticT cell leukemia (CLL)RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MV4-11 Cells300295 Leukemia cell linesHumanBloodAcute monocytic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BALL-1 Cells305084 Leukemia cell linesHumanB LymphocyteB-cell acute lymphoblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
6T-CEM Cells305132 Leukemia cell linesHumanPeripheral bloodT-cell acute lymphoblastic leukemiaAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
HuT-78 Cells300338 Leukemia cell linesHumanBloodMycosis fungoides and Sezary syndromeRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
A3 Cells305143 Leukemia cell linesHumanPeripheral bloodChildhood T acute lymphoblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HEL Cells305022 Leukemia cell linesHumanPeripheral bloodErythroleukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
TK6 Cells300357 Leukemia cell linesHumanSpleenRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BV-173 Cells300133 Leukemia cell linesHumanBloodChronic myeloid leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
KG-1 Cells300208 Leukemia cell linesHumanBone marrowAcute myelogenous leukemiaIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
CCRF-CEM-C7 Cells300398 Leukemia cell linesHumanBloodChildhood T acute lymphoblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MOLT-4 Cells300115 Leukemia cell linesHumanPeripheral bloodAdult T acute lymphoblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Lama-84 Cells300261 Leukemia cell linesHumanBloodChronic myeloid leukemiaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
RPMI 1788 Cells300318 Leukemia cell linesHumanPeripheral bloodRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Kasumi-1 Cells300226 Leukemia cell linesHumanBloodAcute myeloblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Nalm-6 Cells300297 Leukemia cell lines | Human cellsHumanBloodAdult B acute lymphoblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Jurkat Cells302147 LymphomaHumanBloodT-cell acute lymphoblastic leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SU-DHL-4 Cells305106 LymphomaHumanPeritoneal effusionDiffuse large B-cell lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
JeKo-1 Cells305078 LymphomaHumanPeripheral bloodMantle cell lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
H9 Cells300460 LymphomaHumanBloodSezary syndrome (aggressive form of cutaneous T-cell lymphoma)RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
L-428 Cells300200 LymphomaHumanPleural effusionHodgkin lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
L-540 Cells300201 LymphomaHumanBone marrowHodgkin lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
L-591 Cells300202 LymphomaHumanPleural effusionHodgkin lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
DB Cells305048 LymphomaHumanAscitesDiffuse large B-cell lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Farage Cells305071 LymphomaHumanLymphatic systemDiffuse large B-cell lymphoma germinal center B-cell typeRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
OK Cells606465 Opossum cell linesOpossumKidney, cortex, Proximal tubuleEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
B-LCL-CDG4 Cells302015 Rare diseases - cell linesHumanPeripheral bloodCongenital Disorders of GlycosylationRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-CDG2 Cells302013 Rare diseases - cell linesHumanPeripheral bloodCongenital Disorders of GlycosylationRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-CDG7 Cells302018 Rare diseases - cell linesHumanPeripheral bloodCongenital Disorders of GlycosylationRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H295R Cells300483Adrenal gland cancer cell linesHumanAdrenal glandCarcinomaYou can purchase our ready-to-use NCI-H295R Cell Growth Medium (820402) or choose to supplement DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) with the below additives
SW-13 Cells300349Adrenal gland cancer cell linesHumanAdrenal glandSmall cell carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
F81 Cells305015Animal cells | Cat cell linesCatKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Mv.1.Lu Cells305192Animal cells | Mink cell linesNeovison vison (American mink)LungEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
B-LCL-HROC46 Cells302068B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC277 Cells300867B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC278 Cells302051B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
WT51 Cells302141B lymphoblast cell linesHumanPeripheral bloodRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC39 (Bc HROC39) Cells300863B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC06 Cells302065B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC102 Cells302001B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC69 Cells300864B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC24 Cells300861B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HMy2 Cells302008B lymphoblast cell linesHumanHematopoieticPlasma cell leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC112 Cells302023B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC313 (Bc HROC313) Cells302058B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC10 Cells302143B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC118302025B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC113 Cells300898B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC130 Cells302032B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
ARH-77 Cells300306B lymphoblast cell linesHumanBloodPlasma Cell LeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC195 Cells302043B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC32 (Bc HROC32) Cells300862B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HMy2.CIR Cells305126B lymphoblast cell linesHumanB-LymphoblastIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
B-LCL-PB16 Cells302145B lymphoblast cell linesHumanPeripheral bloodRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC173 Cells302039B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROG04 Cells302107B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
IM-9 Cells302151B lymphoblast cell linesHumanBone marrowRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC43 Cells302067B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC50 Cells302069B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC59 Cells302073B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROM01 Cells302079B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC68 Cells302078B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC117 (Bc HROC117) Cells302024B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC103 Cells302020B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
PLH Cells302137B lymphoblast cell linesHumanAdrenal glandClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC60 Cells302004B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
WIL2 Cells302011B lymphoblast cell linesHumanSpleenHereditary spherocytosisRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-LCL-HROC57 Cells302072B lymphoblast cell linesHumanPeripheral bloodCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
FBHE Cells302159Bovine cell linesBovineFetal heartDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MDBK (NBL-1) Cells600396Bovine cell linesBovineKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
PBS860015Buffer and solutions
CA46 Cells305082Burkitt Lymphoma cell linesHumanLymphoblastBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RAJI Cells300359Burkitt Lymphoma cell linesHumanMaxiliaBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
EB1 Cells300403Burkitt Lymphoma cell linesHumanBloodBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BJAB Cells302006Burkitt Lymphoma cell linesHumanBloodBurkitt lymphomaRPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3 (Cytion article number 820702a)
Ramos Cells302007Burkitt Lymphoma cell linesHumanHematopoieticBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Daudi Cells302009Burkitt Lymphoma cell linesHumanBloodBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Raji TK- Cells302161Burkitt Lymphoma cell linesHumanJaw boneBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
COX Cells302138Burkitt Lymphoma cell linesHumanPeripheral bloodBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Raji TK+ Cells302160Burkitt Lymphoma cell linesHumanJaw boneBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
P3HR1 Cells302310Burkitt Lymphoma cell linesHumanBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RJ2.2.5 Cells300360Burkitt Lymphoma cell linesHumanHematopoieticBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
EB3 Cells300373Burkitt Lymphoma cell linesHumanBoneBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Namalwa Cells300439Burkitt Lymphoma cell linesHumanHematopoieticBurkitt lymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Jiyoye Cells300366Burkitt Lymphoma cell linesHumanLymphatic SystemB-cell Non-Hodgkin-LymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MDCK-SIAT1 Cells602281Canine cell linesCanineKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MDCK (NBL-2) Cells602280Canine cell linesCanineKidneyDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
DH82 Cells305003Canine cell linesDogCanine histiocytic sarcomEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
A72 Cells602398Canine cell linesCanineMuscleCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Super Tube Cells305004Canine cell linesDogNormal KidneyDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Cell banking900200Cell banking
Accutase830100Cell Detachment
Cell line authentication - Mouse900654Cell line authentication
Cell line authentication - Hamster900171Cell line authentication
Cell line authentication - Human900154Cell line authentication
Cell line authentication - Rat900172Cell line authentication
Cell line authentication - Dog900170Cell line authentication
DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate820300aClassic Cell Culture Media
DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3820400aClassic Cell Culture Media
Ham's F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3820608aClassic Cell Culture Media
IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3820800aClassic Cell Culture Media
McCoys 5A medium (modified), w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3820200aClassic Cell Culture Media
Ham's F12 Medium, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.176 g/L NaHCO3820600aClassic Cell Culture Media | Cell culture media | Media and Reagents
EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA820100cClassic Cell Culture Media | Cell culture media | Media and Reagents
Medium 199, w: 2.7 mM stable Glutamine, w: 2.2 g/L NaHCO3, w: EBSS820101aClassic Cell Culture Media | Cell culture media | Media and Reagents
RPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3820702aClassic Cell Culture Media | Media and Reagents
RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3820700aClassic Cell Culture Media | Media and Reagents
Freeze Medium CM-1 - 100 ml800100Cryopreservation Media
Freeze Medium CM-1 - 50 ml800050Cryopreservation Media
Freeze medium CM-ACF - serum free - 500 ml806500Cryopreservation Media
Freeze medium CM-ACF - serum free - 50 ml806050Cryopreservation Media
Freeze medium CM-ACF - serum free - 100 ml806100Cryopreservation Media
Freeze Medium CM-1 - 500 ml800500Cryopreservation Media
RT-112 genomic DNA - 5 microgram300324GD5DNA
5637 genomic DNA - 5 microgram300105GD5DNA
T24 genomic DNA - 5 microgram300352GD5DNA
HEK293 genomic DNA - 5 microgram300192GD5DNA
HeLa genomic DNA - 5 microgram300194GD5DNA
BJ Fibroblast Cells305222FibroblastsHuman ForeskinHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
IMR-90 Cells305216FibroblastsHumanFetal lungEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Human Foreskin Fibroblast Cells (HFFC)300715FibroblastsHumanForeskinDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
WI 38 Cells300428FibroblastsHumanLungEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Human Dermal Fibroblast - Adult (HDF-Ad)300606FibroblastsHumanDermisMEM, w/o ribonucleosides, w/o deoxyribonucleosides (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
HROGas03 Cells300437Gastric cancer cell linesHumanStomachGastric adenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
AGS Cells300408Gastric cancer cell linesHumanGastricAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CLS-145 Cells300180Gastric cancer cell linesHumanStomachGastric papillary adenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HGC-27 Cells300436Gastric cancer cell linesHumanGastricGastric adenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCI-N87 Cells305057Gastric cancer cell linesHumanStomachGastric tubular adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MKN-45 Cells300489Gastric cancer cell linesHumanStomachGastric adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MKN-74 Cells300490Gastric cancer cell linesHumanStomachGastric tubular adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MKN-7 Cells305104Gastric cancer cell linesHumanStomachGastric tubular adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
KATO-III Cells300381Gastric cancer cell linesHumanStomachAdenocarcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
HaCaT-ras II-4 Cells300495HaCaT cell linesHumanSkinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HaCaT Cells300493HaCaT cell linesHumanSkinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HaCaT-ras A5 Cells300494HaCaT cell linesHumanSkinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CHO Cells603479Hamster cell linesHamsterOvaryDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
MR1 Cells305000Hamster cell linesAnimal cellsRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
V79 Cells305012Hamster cell linesHamsterLungDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
V79-4 Cells603371Hamster cell linesHamsterLungFibroblastEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
R 1610 Cells305011Hamster cell linesHamsterLungDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CHL Cells305013Hamster cell linesHamsterLungMEM (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
Lec1 Cells305010Hamster cell linesHamsterOvaryAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
CTLA4 Ig-24 Cells305014Hamster cell linesHamsterOvaryDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
BHK-21 clone 13 Cells603126Hamster cell linesHamsterKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
CHO-K1 Cells603480Hamster cell linesHamsterOvaryHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
LS-CLS Cells605390Hamster cell linesHamsterHematopoieticLymphosarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
C918 Cells305109Head-Neck cancer cell linesHumanChoroidUveal melanomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
KTC-1 Cells305113Head-Neck cancer cell linesHumanThyroidThyroid carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
A64-CLS Cells300199Head-Neck cancer cell linesHumanSubmaxillary glandAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
KYSE-30 Cells305094Head-Neck cancer cell linesHumanEsophageal Squamous EpitheliumEsophageal squamous cell carcinomaPlease mix Hams F12 and RPMI 1640 in a 50:50 ratio (Cytion article numbers 820600a and 820702a)
Y-79 Cells300382Head-Neck cancer cell linesHumanRetinaRetinoblastomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CAL 27 Cells305029Head-Neck cancer cell linesHumanTongueTongue squamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HNO223 Cells300142Head-Neck cancer cell linesHumanTongueHead and neck squamous cell carcinoma (HNSCC)DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
BHT101 Cells305112Head-Neck cancer cell linesHumanThyroidAnaplastic thyroid carcinomaMEM (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
Detroit-562 Cells300399Head-Neck cancer cell linesHumanPharynxCarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
CLS-354 Cells300152Head-Neck cancer cell linesHumanOral cavitySquamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
WERI-Rb-1 Cells300632Head-Neck cancer cell linesHumanEyeRetinoblastomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
8305C Cells305101Head-Neck cancer cell linesHumanThyroidThyroid gland anaplastic carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HNO41 Cells300126Head-Neck cancer cell linesHumanTonsilHead and neck squamous cell carcinoma (HNSCC)DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
KYSE-150 Cells305087Head-Neck cancer cell linesHumanEsophagusEsophageal squamous cell carcinomaPlease mix Hams F12 and RPMI 1640 in a 50:50 ratio (Cytion article numbers 820600a and 820702a)
SW-1736 Cells300453Head-Neck cancer cell linesHumanThyroideaSquamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
TTA1 Cells305138Head-Neck cancer cell linesHumanThyroid glandThyroid gland anaplastic carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
FaDu Cells305033Head-Neck cancer cell linesHumanPharynxHypopharyngeal squamous cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RPMI 2650 Cells300323Head-Neck cancer cell linesHumanNasal septumSquamous cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HTh-7 Cells305128Head-Neck cancer cell linesHumanThyroidThyroid gland anaplastic carcinoma
TE-1 Cells305060Head-Neck cancer cell linesHumanEsophagusEsophageal squamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SW-579 Cells300346Head-Neck cancer cell linesHumanThyroideaSquamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
C643 Cells300298Head-Neck cancer cell linesHumanThyroid gland anaplasticAnaplastic thyroid carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HEp-2 Cells300397Head-Neck cancer cell linesHumanLarynxAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HNO97 Cells300129Head-Neck cancer cell linesHumanTongueHead and neck squamous cell carcinoma (HNSCC)DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Colo-680N Cells300464Head-Neck cancer cell linesHumanEsophagusSquamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HNO210 Cells300134Head-Neck cancer cell linesHumanLarynxHead and neck squamous cell carcinoma (HNSCC)DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
KYSE-410 Cells305122Head-Neck cancer cell linesHumanEsophagusEsophageal squamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
KHM-5M Cells305148Head-Neck cancer cell linesHumanThyroidThyroid gland anaplastic carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HNO258 Cells300146Head-Neck cancer cell linesHumanOral cavityHead and neck squamous cell carcinoma (HNSCC)DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
UWO37 Cells300257Head-Neck cancer cell linesHumanOral cavity| tonsilSquamous cell carcinoma of the oropharynxDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
KMH-2 Cells305142Head-Neck cancer cell linesHumanThyroidThyroid gland anaplastic carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
B-CPAP Cells305081Head-Neck cancer cell linesHumanThyroidThyroid carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
UWO23 Cells300258Head-Neck cancer cell linesHumanOral cavity| tongueSquamous cell carcinoma of the oral tongueDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SCC-25 Cells300607Head-Neck cancer cell linesHumanTongueSquamous cell carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
TT Cells305027Head-Neck cancer cell linesHumanThyroid, medullaHereditary thyroid gland medullary carcinoma, Multiple endocrine neoplasia type 2Hams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
TPC-1 Cells305054Head-Neck cancer cell linesHumanThyroidThyroid gland papillary carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CAL-62 Cells305114Head-Neck cancer cell linesHumanThyroidThyroid gland anaplastic carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HUVEC, single donor300605HUVECHumanUmbilical veinEndothelial Cell Growth Medium (Cytion article number 820731)
AC16 Cardiomyocyte Cell Line305215Hybrid cell linesHumanHeart, ventricleDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Sf9 Cells604328Insect cell linesFall armywormOvarySpodopan (PAN Biotech)
HROC32 T3 M1 Cells300819Intestine cancer cell linesHumanColon ascendens, UICC IV, Established from a patient-derived xenograft primary CRC tissue (Colon ascendens, TNM stage T4N2M1R0L0V1 grading G2, Lk(n) + 9, ? Lk(n) 14)AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HuTu-80 Cells300218Intestine cancer cell linesHumanDuodenumAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROC222 T1 M2 Cells300859Intestine cancer cell linesHumanTransverse colonAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC60 Cells300827Intestine cancer cell linesHumanColon ascendens, UICC IPrimary adenocarcinoma, TNM stage T2N0M0R0L0V0, grading G2, Lk(n) + 0, ? Lk(n) 47DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC239 T0 M1 Cells300857Intestine cancer cell linesHumanColon rectum, UICC IIIb, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T4N2M0R0L0V0, grade G2, Lk(n) +7, ? Lk(n) 20).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC278 T0 M1 Cells300835Intestine cancer cell linesHumanColon ascendens, UICC IV, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T4N2M1R0L1V1, grade G3, Lk(n) +19, ? Lk(n) 29).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
RKO-E6 Cells305135Intestine cancer cell linesHumanColonColon carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROC126 Cells300804Intestine cancer cell linesHumanColon rectum, UICC IIIaPrimary adenocarcinoma, TNM stage T3N1M0R0L1V1, grading G2, G3, Lk(n) +2, ? Lk(n) 15DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC183 T0 M2 Cells300810Intestine cancer cell linesHumanColon ascendens, UICC IIIb, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N2M0R0L1V0, grading G3, Lk(n) +12, ? Lk(n) 12).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC183 Cells300809Intestine cancer cell linesHumanColon ascendens, UICC IIIbPrimary adenocarcinoma, TNM stage T3N2M0R0L1V0, grading G3, Lk(n) +12, ? Lk(n) 12DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC87 T0 M2 Cells300831Intestine cancer cell linesHumanColon ascendens, UICC Iia, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N0M0R0L0V0, grade G3, Lk(n) + 0, ? Lk(n) 13).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC374 Cells300852Intestine cancer cell linesHumanColon, sigmoid, ascendensPrimary adenocarcinoma, TNM stage T3N2bM0G3R0L0V1DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HCT-8 Cells300210Intestine cancer cell linesHumanRectumAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC357 Cells300851Intestine cancer cell linesHumanColorectalPrimary adenocarcinoma, TNM stage T3N0M0R0L0V0, grading G2, Lk(n) +0, ? Lk(n) 25DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HCT-15 Cells300229Intestine cancer cell linesHumanColorectalAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HROC59 T1 M1 Cells300826Intestine cancer cell linesHumanColon ascendens, UICC IV, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N1M1R0L1V0, grading G2, Lk(n) + 1, ? Lk(n) 27).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC69 Cells300828Intestine cancer cell linesHumanColon ascendens, UICC IIIaPrimary adenocarcinoma, TNM stage T3N0M1R0L0V0, grading G3, Lk(n) + 0, ? Lk(n) 34DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
RKO-AS45-1 Cells305146Intestine cancer cell linesHumanColonColon carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROC370 Cells300872Intestine cancer cell linesHumanColorectalColon carcinoma, TNM stage T2N0R0L0V0, grading G2, Lk(n) +0, ? Lk(n) 16DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
DLD-1 Cells300220Intestine cancer cell linesHumanColonAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HROC285 T0 M2 Cells300817Intestine cancer cell linesHumanColon, UICC IV, Established from a patient-derived xenograft of primary CRC tissue (Colon descendens, TNM stage T4N2M1R2L1V0, grade G2, Lk(n) +5, ? Lk(n) 20).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC80 T1 M1 Cells300830Intestine cancer cell linesHumanColon coecum, UICC IIIa, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N2M1R0L1V0, grade G2, Lk(n) + 4, ? Lk(n) 17).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC39 Cells300820Intestine cancer cell linesHumanColon ascendens, UICC IIbPrimary adenocarcinoma, TNM stage T4N0M0R0L0V1, grading G3, Lk(n) + 0, ? Lk(n) 34DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC278Met1 T2 M2 Cells300836Intestine cancer cell linesHumanPeritoneal Metastasis, Established from a patient-derived xenograft of metastasis of primary CRC tissue (Colon ascendens, TNM stage T4N2M1R0L1V1, grade G3, Lk(n) +19, ? Lk(n) 29)AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SW-403 Cells300350Intestine cancer cell linesHumanColonAdenocarcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
HROC24 T3 M1 #2 Cells300858Intestine cancer cell linesHumanColonPrimary adenocarcinoma, TNM stage , gradingDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC57 Cells300825Intestine cancer cell linesHumanColon ascendens, UICC IV, Neuroendocrine tumorPrimary adenocarcinoma, TNM stage T3N2M1R2L1V1, grading G3, Lk(n) + 16, ? Lk(n) 28.DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC107 Cells300845Intestine cancer cell linesHumanColon sigmoid, UICC IVPrimary adenocarcinoma, TNM stage T3N2M1R0L1V0, grading G2, Lk(n) +10, ? Lk(n) 18DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC334 Cells300850Intestine cancer cell linesHumanColon coecum, UICC Iia, Primary adenocarcinoma, TNM stage T3N0M0R0L0V0, grading G2, Lk(n) +0, ? Lk(n) 40AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC147Met Cells300806Intestine cancer cell linesHumanColorectalAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Colo-205 Cells300380Intestine cancer cell linesHumanColon, Dukes type DColorectal adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HROC309 Cells300837Intestine cancer cell linesHumanColorectalPrimary adenocarcinoma, TNM stage T3N0M0R0L0V1 grading G2, Lk(n) +0, ? Lk(n) 23DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC364 Cells300855Intestine cancer cell linesHumanRight FlexurPrimary adenocarcinoma, TNM stage T3N0M0R0L0V0, grading G2, Lk(n) +0, ? Lk(n) 22DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC277Met2 Cells300848Intestine cancer cell linesHumanColorectalAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC24 Cells300812Intestine cancer cell linesHumanColorectalPrimary adenocarcinoma, TNM stage T2N0M0R0L0V1, grading G2 Lk(n) + 0, ? Lk(n) 13DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC32 Cells300818Intestine cancer cell linesHumanColon ascendens, UICC IVPrimary adenocarcinoma, TNM stage T4N2M1R0L0V1 grading G2, Lk(n) + 9, ? Lk(n) 14DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Colo-320DM Cells300153Intestine cancer cell linesHumanColon, Dukes type CColorectal adenocarcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
HROC43 Cells300823Intestine cancer cell linesHumanColon ascendens, UICC IIIbPrimary adenocarcinoma, TNM stage T3N2M0R0L1V0, grading G3, Lk(n) + 30, ? Lk(n) 36DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SW-620 Cells300466Intestine cancer cell linesHumanColorectalAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HROC24 T1 M1 Cells300813Intestine cancer cell linesHumanColon, Established from a PDx (patient-derived xenograft) of primary CRC tissue (Colon ascendens, UICC I, TNM stage T2N0M0R0L0V1 grading G2). Lk(n) + 0, ? Lk(n) 13EpithelialDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC277 T0 M1 Cells300834Intestine cancer cell linesHumanColon coecum, UICC IV, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T4N0M1R0L0V0, grade G2, Lk(n) +0, ? Lk(n) 12)AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC383 Cells300873Intestine cancer cell linesHumanColon transversumPrimary adenocarcinoma, TNM stage T3N0M0R0L0V0, grading G3, Lk(n) + 0, ? Lk(n) 39DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
WiDr Cells300377Intestine cancer cell linesHumanColonAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC296 Cells300853Intestine cancer cell linesHumanColon ascendens, UICC IiaPrimary adenocarcinoma, TNM stage T3N0M0R0L0V0, grading G2, Lk(n) +0, ? Lk(n) 35DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC50 T1 M5 Cells300839Intestine cancer cell linesHumanColon ascendens, UICC Iib, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T4N0M0R0L0V0, grading G2, Lk(n) + 0, ? Lk(n) 34)AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
CW-2 Cells305134Intestine cancer cell linesHumanColonColon adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HROC131 T0 M3 Cells300805Intestine cancer cell linesHumanColon ascendens, UICC IIIa, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N1M0R0L0V0, grade G3, Lk(n) +2, ? Lk(n) 22).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC212 Cells300811Intestine cancer cell linesHumanColon coecum, UICC IVPrimary adenocarcinoma, TNM stage T4N2M1R0 L1 V0 , grading G3, Lk(n) +7, ? Lk(n) 20DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Colo-60H Cells300456Intestine cancer cell linesHumanColon transversumAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC324 Cells300838Intestine cancer cell linesHumanColon coecum, UICC IIIbPrimary adenocarcinoma, TNM stage T3N2M0R0L1V0, grading G3, Lk(n) +5, ? Lk(n) 24DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HHC6548 T1 M1 Cells300832Intestine cancer cell linesHumanColon ascendens, UICC IIIc, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N2Mx, grade G3).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
LoVo Cells300266Intestine cancer cell linesHumanColon, grade IV, Dukes type CAdenocarcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
SW-948 Cells300347Intestine cancer cell linesHumanColonAdenocarcinoma, grade III, Dukes type CEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROC46 T0 M1 Cells300824Intestine cancer cell linesHumanColon ascendens, UICC IV, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N0M1R2L0V1, grading G3, Lk(n) + 0, ? Lk(n) 34)AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SW-480 Cells300302Intestine cancer cell linesHumanColonAdenocarcinoma, Grade IV, Dukes type B.Hams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
HROC103 T0 M1 Cells300802Intestine cancer cell linesHumanColorectal, Established from a PDx (patient-derived xenograft) of primary CRC tissue (Colon ascendens, TNM stage T2N1M0R0L0V0, grade G2, Lk(n) + 2, ? Lk(n) 23).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCI-H716 Cells305079Intestine cancer cell linesHumanCecumCecum adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HROC284Met Cells300816Intestine cancer cell linesHumanLiver MetastasisAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
LS-174T Cells300392Intestine cancer cell linesHumanColonAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
T84 Cells300354Intestine cancer cell linesHumanColonCarcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
HT-29 Cells300215Intestine cancer cell linesHumanColonAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Colo-94H Cells300161Intestine cancer cell linesHumanColonAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC300 T2 M1 Cells300866Intestine cancer cell linesHumanColorectalAdenocarcinoma, TNM stage T4aN1bM1R2L0V1, grading G2, Lk(n) + 3, ? Lk(n) 22DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SW-1116 Cells300348Intestine cancer cell linesHumanColonAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
CX-1 Cells300159Intestine cancer cell linesHumanColonAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SW-1463 Cells300623Intestine cancer cell linesHumanRectumRectal adenocarcinomaLeibovitzs L-15, w: 2.0 mM L-Glutamine, 0.55 g/L NaHCO3 (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
HROBMC01 Cells300800Intestine cancer cell linesHumanColorectalAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
RKO Cells305035Intestine cancer cell linesHumanColonColon carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROC257 T0 M1 Cells300815Intestine cancer cell linesHumanColon ascendens, UICC IV, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T4N2Mx,R1L1V1 grading G3, Lk(n) +8, ? Lk(n) 15).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
LS-513 Cells300457Intestine cancer cell linesHumanColorectalAdenocarcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
HROC39 T0 M2 Cells300821Intestine cancer cell linesHumanColon ascendens, UICC Iib, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T4N0M0R0L0V1, grading G3, Lk(n) + 0, ? Lk(n) 34).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HCT116 Cells300195Intestine cancer cell linesHumanColorectalAdenocarcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
HROC147 T0 M1 Cells300856Intestine cancer cell linesHumanColon recto-sigmoid, UICC IV, Established from a patient-derived xenograft of primary CRC tissue (Colon sigmoid, TNM stage T3N2M1R0L1V1, grade G3, Lk(n) +4, ? Lk(n) 32).AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC348Met Cells300871Intestine cancer cell linesHumanLiver metastasisAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC40 Cells300822Intestine cancer cell linesHumanColon descendens, UICC IIIaPrimary adenocarcinoma, TNM stage T3N1M0R0L1V1, grading G3, Lk(n) + 2, ? Lk(n) 18DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Caco2 Cells300137Intestine cancer cell linesHumanColonAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HROC113 Cells300803Intestine cancer cell linesHumanColon ascendens, UICC IVPrimary adenocarcinoma, TNM stage T4N2M0R0, grading G3, Lk(n) +5, ? Lk(n) 45DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCI-H508 Cells305107Intestine cancer cell linesHumanLarge intestine, CecumCecum adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HROC69 T0 M2 Cells300829Intestine cancer cell linesHumanColon ascendens, UICC IIIa, Established from a patient-derived xenograft of primary CRC tissue (Colon ascendens, TNM stage T3N0M1R0L0V0, grading G3, Lk(n) + 0, ? Lk(n) 34)AdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC18 Cells300808Intestine cancer cell linesHumanColon (coecum), UICC IPrimary adenocarcinoma, TNM stage T2N0M0 R0L0V0, grading G2, Lk(n) + 0, ? Lk(n) 28DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC173 Cells300807Intestine cancer cell linesHumanColon ascendens, UICC IVPrimary adenocarcinoma, TNM stage T4N2M1R2L0V grading G3, Lk(n) +11, ? Lk(n) 29DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC313Met Cells300849Intestine cancer cell linesHumanLung MetastasisAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HRT-18300230Intestine cancer cell linesHumanRectumAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HROC257 Cells300814Intestine cancer cell linesHumanColon ascendens, UICC IVPrimary adenocarcinoma, TNM stage T4N2Mx,R1L1V1 grading G3, Lk(n) +8, ? Lk(n) 15DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Caki-2 Cells300140Kidney cancer cell linesHumanKidneyPapillary carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Wilms3 Cells300414Kidney cancer cell linesHumanKidneyWilms tumorMSCGM kit (from Lonza)
RCC-FG1 Cells300248Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT2a, M1/ GIIRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Caki-1 Cells300149Kidney cancer cell linesHumanKidneyClear cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RCC-FG2 Cells300249Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT2a, Nx, M1/GIIRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-MF Cells300245Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT2, N1, Mx/ GII-III (lung- metastasisRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Wilms8 Cells300416Kidney cancer cell linesHumanKidneyWilms tumorMSCGM kit (from Lonza)
Wilms6 Cells300415Kidney cancer cell linesHumanKidneyWilms tumorMSCGM kit (from Lonza)
Wilms2 Cells300413Kidney cancer cell linesHumanKidneyWilms tumorMSCGM kit (from Lonza)
Wilms11 Cells300420Kidney cancer cell linesHumanKidneyWilms tumorMSCGM kit (from Lonza)
RCC-ER Cells300238Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT3a, N1, Mx/GIIRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-KL Cells300281Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-PR Cells300267Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
A498 Cells300113Kidney cancer cell linesHumanKidneyRenal cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
769-P Cells300106Kidney cancer cell linesHumanKidneyRenal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
ImWilms10T Cells300419Kidney cancer cell linesHumanKidneyWilms TumorMSCGM kit (from Lonza)
A704 Cells300217Kidney cancer cell linesHumanKidneyAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RCC-MH Cells300237Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT2, No, M0/GIIRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
ACHN Cells300117Kidney cancer cell linesHumanKidneyAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SK-NEP-1 Cells300341Kidney cancer cell linesHumanKidneyWilms tumorMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
RCC-KP Cells300254Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Wilms10T Cells300417Kidney cancer cell linesHumanKidneyWilms tumorMSCGM kit (from Lonza)
OS-RC-2 Cells305086Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-WK Cells300243Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT3b, No, Mx/ GIIRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-GH Cells300252Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-LR Cells300236Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-JF Cells300274Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
RCC-GS Cells300241Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT3b, No, M1/ GIII (brain metastasis)McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
RCC-JW Cells300244Kidney cancer cell linesHumanKidneyClear cell renal cell carcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
RCC-OF1 Cells300255Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT2, Nx, Mx/GIRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
imWilms1 Cells300412Kidney cancer cell linesHumanKidneyWilms TumorMSCGM kit (from Lonza)
WT-CLS1 Cells300379Kidney cancer cell linesHumanKidneyRhabdoid tumorIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
786-O Cells300107Kidney cancer cell linesHumanKidneyRenal cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RCC-HB Cells300253Kidney cancer cell linesHumanKidneyClear cell renal cell carcinoma, pT3a, Mo, No, GI-IIRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Wilms1 Cells300411Kidney cancer cell linesHumanKidneyMSCGM kit (from Lonza)
AAV-293 Cells305127Kidney cancer cell lines | Human cells | Transformed cell linesHumanEmbryonic kidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HEK293T/17 Cells305117Kidney cancer cell lines | Human cells | Transformed cell linesHumanEmbryonic kidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HEK293 Cells300192Kidney cancer cell lines | Transformed cell linesHumanKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HEK293T Cells300189Kidney cancer cell lines | Transformed cell linesHumanKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HEK293 suspension-adapted300686Kidney cancer cell lines | Transformed cell linesHumanKidneyPanserin 293S (from PanBiotech)
2V6.11 Cells305147Kidney cancer cell lines | Transformed cell lines | Human cellsHumanFetal KidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HEP3B Cells305141Liver cancer cell linesHumanLiverChildhood hepatocellular carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HuH-6 Cells305092Liver cancer cell linesHumanLiverHepatoblastomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HROHep03 Cells300197Liver cancer cell linesHumanLiverPrimary adenocarcinoma, T0NxMx stage, grade 3DMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HepG2 Cells300198Liver cancer cell linesHumanLiverHepatocellular carcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
SK-HEP-1 Cells300334Liver cancer cell linesHumanLiverAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Li-7 Cells305102Liver cancer cell linesHumanLiverAdult hepatocellular carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Chang Liver (HeLa) Cells300139Liver cancer cell linesHumanLiverAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RBE Cells305019Liver cancer cell linesHumanBile ductIntrahepatic cholangiocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HuH7 Cells300156Liver cancer cell linesHumanLiverHepatocellular carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HuCC-T1 Cells300469Liver cancer cell linesHumanLiverIntrahepatic cholangiocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
PLC/PRF/5 Cells300315Liver cancer cell linesHumanHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Mahlavu Cells300473Liver cancer cell linesHumanLiverHepatocellular carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
NCI-H441 Cells305219Lung cancer cell linesHumanLungPapillary adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
H-MESO-1 Cells300186Lung cancer cell linesHumanLungPleural MesotheliomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
DMS-79 Cells300164Lung cancer cell linesHumanLungCarcinoma, azaserine inducedRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H520 Cells305063Lung cancer cell linesHumanLungLung squamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H196 Cells300390Lung cancer cell linesHumanLungLung small cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H358 Cells300430Lung cancer cell linesHumanLungMinimally invasive lung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HARA-B Cells300465Lung cancer cell linesHumanLungLung squamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H1703 Cells305090Lung cancer cell linesHumanLungLung squamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SCLC-22H Cells300445Lung cancer cell linesHumanLungSmall cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Calu-6 Cells300135Lung cancer cell linesHumanLungAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
H-MESO-1A Cells300187Lung cancer cell linesHumanLungPleural MesotheliomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NCI-H157 Cells300387Lung cancer cell linesHumanLungLung squamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H1563 Cells305131Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SK-LU-1 Cells300335Lung cancer cell linesHumanLungAdenocarcinoma (grade III)EMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SW2300396Lung cancer cell linesHumanLungSmall cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SCLC-21H Cells300225Lung cancer cell linesHumanLungCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NCI-H1299-EGFP Cells300272Lung cancer cell linesHumanLungLarge cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H23 Cells305044Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
A549/DDP Cells305047Lung cancer cell linesHumanLungHams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
NCI-H2126 Cells300639Lung cancer cell linesHumanLungLung large cell carcinomaHITES (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
NCI-H1975 Cells305067Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SV-80 Cells300345Lung cancer cell linesHumanSkinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
A427 Cells300111Lung cancer cell linesHumanLungCarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
NCI-H647 Cells305130Lung cancer cell linesHumanLungLung adenosquamous carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LCLC-103H Cells300169Lung cancer cell linesHumanLungLarge cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Calu-1 Cells300141Lung cancer cell linesHumanLungCarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
NCI-H146 Cells300182Lung cancer cell linesHumanLungSmall cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
2106T Cells300165Lung cancer cell linesHumanLungSquamous cell carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCI-H1568 Cells305137Lung cancer cell linesHumanLymph nodeLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H1650 Cells305059Lung cancer cell linesHumanLungMinimally invasive lung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CLS-54 Cells300227Lung cancer cell linesHumanLungAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LCLC-97TM1 Cells300409Lung cancer cell linesHumanLungLarge cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HCC78 Cells302156Lung cancer cell linesHumanPleural effusionAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H69 Cells300185Lung cancer cell linesHumanLungLung small cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HCC366 Cells302155Lung cancer cell linesHumanLungAdenosquamous carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H524 Cells305120Lung cancer cell linesHumanLungLung small cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H1299 Cells300485Lung cancer cell linesHumanLungCarcinomaRPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3 (Cytion article number 820702a)
HEL-299 Cells300193Lung cancer cell linesHumanLungHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
NCI-H460 Cells305020Lung cancer cell linesHumanLungLung large cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H2347 Cells305139Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
GCT Cells300155Lung cancer cell linesHumanLungUndifferentiated pleomorphic sarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
NCI-H1437 Cells305110Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H2452 Cells300391Lung cancer cell linesHumanLungPleural biphasic mesotheliomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
2427T Cells300167Lung cancer cell linesHumanLungLung squamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
PC-9 Cells305045Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H292 Cells305040Lung cancer cell linesHumanLungLung mucoepidermoid carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H2228 Cells305125Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LXF-289 Cells300269Lung cancer cell linesHumanLungAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H446 Cells305049Lung cancer cell linesHumanLungLung small cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H838 Cells305097Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H226 Cells305091Lung cancer cell linesHumanLungPleural epithelioid mesotheliomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MSTO-211H Cells300450Lung cancer cell linesHumanLungPleural mesotheliomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H209 Cells300183Lung cancer cell linesHumanLungSmall cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCI-H82 Cells300442Lung cancer cell linesHumanLungLung small cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Calu-3 Cells305032Lung cancer cell linesHumanLung adenocarcinomaLung adenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
NCI-H661 Cells305085Lung cancer cell linesHumanLungLung large cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HCC827 Cells305041Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
WI 38 VA13 subline 2RA Cells300421Lung cancer cell linesHumanLungEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
NCI-H1944 Cells305123Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SK-MES-1 Cells300339Lung cancer cell linesHumanLungSquamous cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
NCI-H1395 Cells305118Lung cancer cell linesHumanLungLung adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SCLC-24H Cells300177Lung cancer cell linesHumanLungSmall cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
A549 Cells300114Lung cancer cell linesHumanLungCarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NCI-H3122 Cells300484Lung cancer cell linesHumanLungAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BGM Cells302158Monkey cell linesVervet monkeyKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Vero E6 Cells305008Monkey cell linesChlorocebus sabaeus (Green monkey)Normal KidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
COS-1 Cells305005Monkey cell linesCercopithecus aethiops (Green monkey)KidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
BS-C-1 Cells305009Monkey cell linesChlorocebus pygerythrus (Vervet monkey)KidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RF/6A Cells305150Monkey cell linesRhesus macaqueChoroid, retinaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
FRhK-4 Cells305151Monkey cell linesRhesus macaqueEmbryonic kidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
VERO Cells605372Monkey cell linesChlorocebus sabaeus (Green monkey)KidneyDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
COS-7 Cells605470Monkey cell linesCercopithecus aethiops (Green monkey)KidneyDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
LLC-MK2 Cells305149Monkey cell linesRhesus macaqueKidneyMedium 199, w: 2.7 mM stable Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820101a)
CV-1 Cells605471Monkey cell linesMonkeyKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
MARC-145 Cells305006Monkey cell linesChlorocebus pygerythrus (Vervet monkey)Embryonic kidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MA-104 Cells305007Monkey cell linesChlorocebus pygerythrus (Vervet monkey)KidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
B95-8 Cells601102Monkey cell lines | Animal cellsCotton-top tamarinBloodRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MC3T3-E1 Cells305187Mouse cell linesMouseBone, calvariaAlpha MEM, w: 2.0 mM stable Glutamine, w: Ribonucleosides, w: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3, w/o: Ascorbic acid
MC38 Cells305223Mouse cell linesMouseColonAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Ba/F3 Cells305224Mouse cell linesMouseBone marrowRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
AE-1 Cells300635Mouse cell linesMouseHybridomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
RenCa Cells400321Mouse cell linesMouseKidneyCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
C127I Cells400134Mouse cell linesMouseBreast, mammary glandCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
LA795 Cells300472Mouse cell linesMouseLungAdenocarcinoma of the mouse pulmonary system
Sp2/0-Ag14 Cells400481Mouse cell linesMouseBloodB cell hybridomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
TRI-C3H Cells400359Mouse cell linesMouseSkinTrichoepitheliomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
35.1 Cells305002Mouse cell linesMouseRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
AtT-20 Cells305161Mouse cell linesMousePituitaryMouse pituitary gland neoplasmsHams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
Beta-TC-6 Cells305181Mouse cell linesMousePancreasMouse insulinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SAT Cells400332Mouse cell linesMouseBreastMalignant neoplasms of the mouse mammary glandRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
WEHI-3B Cells400376Mouse cell linesMousePeripheral bloodLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HT22 Cells305158Mouse cell linesMouseBrain, hippocampusDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
C127 Cells305169Mouse cell linesMouseMammary glandMalignant neoplasms of the mouse mammary glandDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Hep-CLS-C9 Cells400195Mouse cell linesMouseLiverHepatocellular carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Colon-26 Cells400156Mouse cell linesMouseColonCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
FS-Balb Cells400272Mouse cell linesMouseSkinFibrosarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SV40 MES 13 Cells305183Mouse cell linesMouseKidney, glomerulusDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
B16 Cells305154Mouse cell linesMouseSkinMouse melanomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
KLN-205 Cells400419Mouse cell linesMouseLungSquamous cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
ASB-XIV Cells400120Mouse cell linesMouseLungPulmonary squamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Neuro-2a Cells400394Mouse cell linesMouseNeuroblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
TM4 Cells305170Mouse cell linesMouseTestisDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
EGG Cells400171Mouse cell linesMouseBloodLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NS-1 (P3/NS/1-Ag4.1) Cells400108Mouse cell linesMouseMyelomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
P19 Cells400416Mouse cell linesMouseTestisTeratocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
M2-10B4 Cells400428Mouse cell linesMouseBone marrowRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
L5178-R Cells400258Mouse cell linesMouseThymusLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
AE-2 Cells300638Mouse cell linesMouseHybridomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
BNL CL.2 Cells305177Mouse cell linesMouseLiverDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
P3X63Ag8 Cells305171Mouse cell linesMouseB Lymphocyte, Phlogocyte, MyelomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CT26.WT Cells305178Mouse cell linesMouseColonMouse colon adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NIH-3T3-ras Cells400100Mouse cell linesMouseEmbryonicDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
B16-F0 Cells300308Mouse cell linesMouseSkinMouse melanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CLS-CD-3575 Cells400146Mouse cell linesMouseKidneyCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
EL4.IL-2 Cells400425Mouse cell linesMouseThymusLymphomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MFC Cells300652Mouse cell linesMouseStomachMouse gastric carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Meth A sarcoma Cells400284Mouse cell linesMouseSkinFibrosarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NFS-60 Cells400301Mouse cell linesMouseBloodLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
C2C12 Cells400476Mouse cell linesMouseMuscleRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
EAT Cells400169Mouse cell linesMouseBreastAdenocarcinomaNCTC-135 (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
4T1 Cells300300Mouse cell linesMouseBreast, mammary glandMalignant neoplasmRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
F9 Cells400174Mouse cell linesMouseTestisTeratocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
PDV Cells400314Mouse cell linesMouseSkinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
GC-1 spg Cells300375Mouse cell linesMouseTestisDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MH-S Cells300487Mouse cell linesMouseLungRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SVI Cells400495Mouse cell linesMouseKidneyRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Hep-66.3A Cells400206Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NE-4C Cells305182Mouse cell linesMouseBrain, NeuroectodermalEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Hep-64.1 Cells400205Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
P3X63Ag8.653 Cells400118Mouse cell linesMouseHematopoieticMyelomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RAW 264.7 Cells400319Mouse cell linesMouseAscitesLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
3T6-Swiss albino Cells400104Mouse cell linesMouseEmbryonicHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
Hep-70.4 Cells400207Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
LLC1 Cells400263Mouse cell linesMouseLungMalignant tumors of the mouse pulmonary systemRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
GC-2spd(ts) Cells300376Mouse cell linesMouseTestisDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MS1 Cells305172Mouse cell linesMouseBone marrow
L-138 Cells400384Mouse cell linesMouseHematopoietic, hybridomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CLS-103 Cells400176Mouse cell linesMouseStomachSquamous cell carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
3T3-Swiss albino Cells400103Mouse cell linesMouseEmbryonicDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CDNR4 Cells400391Mouse cell linesMouseBreastAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
40817 Cells300500Mouse cell linesMouseHybridomaLeukemiaIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
Hep-56.1B Cells400202Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CTLL-2 Cells400482Mouse cell linesMouseBloodi2Cult (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
Y-1 Cells400477Mouse cell linesMouseAdrenal glandCarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Hep-CLS-1W Cells400414Mouse cell linesMouseLiverHepatocellular carcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
MSC-P5 Cells400294Mouse cell linesMouseSkinEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
BV2 Cells305156Mouse cell linesMouseBrainRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BALB/3T3 clone A31 Cells305155Mouse cell linesMouseEmbryoDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Hep-56.1D Cells400204Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
RM-1 Cells305168Mouse cell linesMouseProstateCarcinoma of the mouse prostate glandDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
E11 Cells400494Mouse cell linesMouseKidneyRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
P388-D1 Cells400308Mouse cell linesMouseHematopoieticLymphoid neoplasmaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
L-929 Cells400260Mouse cell linesMouseConnective tissue, normal, subcutaneous, areolar and adiposeDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Yac-1 Cells400383Mouse cell linesMouseLymph nodeLymphomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
AML12 Cells300643Mouse cell linesMouseLiverDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
OP9 Cells305174Mouse cell linesMouseBone marrow, stromaAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
L6565 Cells305189Mouse cell linesMousePeripheral bloodDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Hep-53.4 Cells400200Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Hepa 1-6 Cells400474Mouse cell linesMouseLiverHepatocellular carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
WEHI-3 Cells400381Mouse cell linesMousePeripheral bloodLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CaD2 Cells400138Mouse cell linesMouseBreast, mammary glandCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
OCD Cells400417Mouse cell linesMouseBoneOsteochondromaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
WEHI-164 Cells400438Mouse cell linesMouseFibrosarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
OKT 3 Cells300499Mouse cell linesMouseSpleenIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
MA-Balb Cells400270Mouse cell linesMouseBreastMalignant neoplasms of the mouse mammary glandDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
P-815 Cells400242Mouse cell linesMouseHematopoieticMastocytomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
PCC4-aza1 Cells400313Mouse cell linesMouseTestisTeratocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
MCA-3D Cells400437Mouse cell linesMouseSkinHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
B16-F1 Cells400122Mouse cell linesMouseSkinMelanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
C8-D1A Cells300316Mouse cell linesMouseBrainDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
TM3 Cells305167Mouse cell linesMouseTestisDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
EMT6 Cells305159Mouse cell linesMouseBreastMalignant neoplasms of the mouse mammary glandDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
FS-C57BL Cells400420Mouse cell linesMouseSkinSarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RAG Cells305190Mouse cell linesMouseKidneyMouse kidney carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
EL4 Cells300653Mouse cell linesMouseMouse precursor T cell lymphoblastic lymphoma/leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
M-MSV-Balb/3T3 Cells400458Mouse cell linesMouseEmbryonicDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
FS-C3H Cells400418Mouse cell linesMouseSkinFibrosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Hep-CLS-1H Cells400197Mouse cell linesMouseLiverAdenocarcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
Hep-CLS-E1 Cells400196Mouse cell linesMouseLiverHepatocellular carcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
LM/TK(LMTK-) Cells305176Mouse cell linesMouseSubcutaneous Connective Tissue, Mammary Areola And FatDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
B82 Cells305173Mouse cell linesMouseSkinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
B16-F10 Cells305157Mouse cell linesMouseSkinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
A9 Cells305166Mouse cell linesMouseSubcutaneous Connective Tissue, Loose Connective Tissue And Fat, NormalDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
RenCa-IL2 Cells400322Mouse cell linesMouseKidneyCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
15P-1 Cells305191Mouse cell linesMouse, transgenicTestisDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
J774A.1 Cells400220Mouse cell linesMouseReticulumSarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Hep-56.1C Cells400203Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Panc02 Cells300501Mouse cell linesMousePancreasMouse pancreatic ductal adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
PECA Cells400189Mouse cell linesMouseSkinSquamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
H22 Cells305163Mouse cell linesMouseLiverHepatocellular carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
NCTC clone 1469 Cells400300Mouse cell linesMouseLiverRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Kera-308 Cells400429Mouse cell linesMouseSkinPapilloma of the mouse skinDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
C3H/10T1/2 Clone 8 Cells305164Mouse cell linesMouseEmbryoBME, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (We do not supply BME| please consider other suppliers. Please let us know if you need further assistance)
DS19 Cells305153Mouse cell linesMouseMouse erythroid leukemia
3T3-L1 Cells400107Mouse cell linesMouseEmbryonicDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Psi2 DAP Cells305179Mouse cell linesMouseNormal EmbryoDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
STO Cells400165Mouse cell linesMouseEmbryonicEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SVEC4-10 Cells305180Mouse cell linesMouseAxillary NodesDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MIN-6 Cells302148Mouse cell linesMousePancreas, islets of LangerhansMouse insulinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
L1210 Cells400257Mouse cell linesMouseHematopoieticLeukemiaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Hep-55.1C Cells400201Mouse cell linesMouseLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
L-WRN Cells300641Mouse cell linesMouseConnective tissueDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NIH-3T3 Cells400101Mouse cell linesMouseEmbryonicDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
MC3T3-E1 Subclone 14 Cells305185Mouse cell linesMouseBone, calvariaAlpha MEM, w: 2.0 mM stable Glutamine, w: Ribonucleosides, w: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3, w/o: Ascorbic acid
TERA-C3H Cells400360Mouse cell linesMouseOvaryTeratomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MC3T3-E1 Subclone 24 Cells305186Mouse cell linesMouseBoneAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
CLS-138 Cells400177Mouse cell linesMouseSkinSarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Hep-74.3A Cells400208Mouse cell linesMouseLiverHepatocellular carcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
K7M2 wt Cells305188Mouse cell linesMouseAscitesMouse osteosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HC11 Cells305050Mouse cell lines | Human cellsHumanMammaryRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Rapid Mycoplasma Test900159Mycoplasma detection test
Premium Mycoplasma Test900164Mycoplasma detection test
RPMI 8226 Cells300431Myeloma cell linesHumanPeripheral bloodMultiple MyelomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MOLP-8 Cells304082Myeloma cell linesHumanBone marrowMultiple myelomaRPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3 (Cytion article number 820702a)
U266 Cells300259Myeloma cell linesHumanPlasma cellMultiple MyelomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
GIMEN Cells300179Neuroblastoma cell linesHumanBrainNeuroblastomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
IMR-32 Cells300148Neuroblastoma cell linesHumanBrainNeuroblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SK-N-SH Cells305028Neuroblastoma cell linesHumanBrainNeuroblastomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SK-N-BE(2) Cells305058Neuroblastoma cell linesHumanBrainNeuroblastomaPlease mix EMEM and Hams F12 in a 50:50 ratio (Cytion article numbers 820100c and 820600a)
Kelly Cells300317Neuroblastoma cell linesHumanBrainNeuroblastomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
SH-SY5Y Cells300154Neuroblastoma cell linesHumanBone MarrowNeuroblastomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SK-N-LO Cells300400Neuroblastoma cell linesHumanBrainPrimitive Neuroectodermal tumorEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Human Dental Pulp Stem Cells (hDPSC) Cells300702Oral cellsHumanDentalAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Gingival Fibroblasts (hGF)300703Oral cells | FibroblastsHumanGingivaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
DAN-G Cells300162Pancreas cancer cell linesHumanPancreasAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
FAMPAC Cells300309Pancreas cancer cell linesHumanPancreasAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Panc 10.05 Cells300599Pancreas cancer cell linesHumanPancreasPancreatic ductal adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MIA PaCa-2 Cells300438Pancreas cancer cell linesHumanPancreasDuctal adenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
AsPC-1 Cells300158Pancreas cancer cell linesHumanPancreasAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Panc-1 Cells300228Pancreas cancer cell linesHumanPancreasAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
FAMPAC-A Cells300310Pancreas cancer cell linesHumanPancreasAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Capan-1 Cells300143Pancreas cancer cell linesHumanPancreasDuctal adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HPAF-II Cells305088Pancreas cancer cell linesHumanPancreasPancreatic ductal adenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SW 1990 Cells305068Pancreas cancer cell linesHumanPancreasPancreatic adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CFPAC-1 Cells305066Pancreas cancer cell linesHumanPancreasCystic fibrosis, Pancreatic ductal adenocarcinomaIMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
PATU8988T Cells305133Pancreas cancer cell linesHumanPancreasPancreatic adenocarcinomaMEM (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
Capan-2 Cells300144Pancreas cancer cell linesHumanPancreasAdenocarcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
BxPC-3 Cells305031Pancreas cancer cell linesHumanPancreasPancreatic ductal adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
ST Cells305214Pig cell linesPigTestisEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
IBRS-2 Cells305212Pig cell linesPigKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
PIEC Cells305213Pig cell linesPigVascular endothelium
PEDSV.15 Cells305211Pig cell linesPigAorta, endothelium
LLC-PK1 Cells607264Pig cell linesSus ScrofaKidneyDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
PK-15 Cells607426Pig cell linesPigKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
PtK1 Cells608393Potoroo cell linesPotorooKidneyRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
PtK2 Cells608316Potoroo cell linesPotorooKidneyRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LNCaP clone FGC Cells305220Prostate cancer cell linesHumanProstateCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
PC-3 Cells300312Prostate cancer cell linesHumanProstateAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
LNCaP Cells300265Prostate cancer cell linesHumanProstateCarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
22RV1 Cells305037Prostate cancer cell linesHumanProstateProstate carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
VCaP Cells300631Prostate cancer cell linesHumanProstateProstate carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
DU-145 Cells300168Prostate cancer cell linesHumanProstateCarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
PC-3M Cells305061Prostate cancer cell linesHumanProstateProstate carcinomaHams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
NR8383 Cells305200Rat cell linesRatLungHams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
INS-1 Cells300471Rat cell linesRatPancreas, islets of LangerhansRat insulinomaRPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3 (Cytion article number 820702a)
9L/lacZ Cells305208Rat cell linesRatBrainRat malignant gliomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HSC-T6 Cells305199Rat cell linesRatLiverDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
OS1-CLS Cells500369Rat cell linesRatBoneOsteosarcomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
BRL-3A Cells500129Rat cell linesRatLiverHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
H9c2(2-1) Cells305203Rat cell linesRatHeart, myocardiumDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
AS-30D Cells500116Rat cell linesRatLiverHepatocellular carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
AT-1 Cells500121Rat cell linesRatProstateAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
UMR-106 Cells305197Rat cell linesRatBoneRat osteosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HB-CLS-3 Cells500460Rat cell linesRatBladderCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
H-4-II-E Cells305204Rat cell linesRatLiverRat hepatocellular carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
AR42J Cells500478Rat cell linesRatPancreas tumor, exocrineNeoplasiaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
FRTL Cells500202Rat cell linesRatThyroideaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
MMQ Cells300498Rat cell linesRatBrainRat pituitary gland neoplasmRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
LC-540 Cells500262Rat cell linesRatTestisAdenomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
FRTL-5 Cells500407Rat cell linesRatThyroideaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
RTE-2 Cells500327Rat cell linesRatTongueDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Y3-Ag 1.2.3 Cells305207Rat cell linesRatPlaemocytoma, MyelomaRat plasma cell myelomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Walker-256 Cells500375Rat cell linesRatMammary glandAdenocarcinoma of the rat mammary glandRPMI 1640, w: 4.5 g/L Glucose, w: 2 mM L-Glutamine, w: 10 mM HEPES, w: 1 mM Sodium pyruvate, w: 1.5 g/L NaHCO3 (Cytion article number 820702a)
IEC-6 Cells302149Rat cell linesRatSmall intestineDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MADB106 Cells305205Rat cell linesRatAdenocarcinoma of the rat mammary glandRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
DSL-6A-C1 Cells500166Rat cell linesRatPancreasCarcinoma, azaserine inducedWaymouth medium (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
MH-3924A Cells500286Rat cell linesRatLiverHepatocellular carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NRK Cells305195Rat cell linesRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NRK-49F Cells500427Rat cell linesRatKidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RSC96 Cells305202Rat cell linesRatNeuronal, spontaneously transformedDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
RY(ham) Yoshida Sarcoma Cells500415Rat cell linesRatSarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Novikoff Hepatoma Cells500373Rat cell linesRatLiverHepatocellular carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
PC-12 Cells500311Rat cell linesRatAdrenal glandPheochromocytomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
GH3 Cells300383Rat cell linesRatBrain, Pituitary glandNeoplasmHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
A7r5 Cells305198Rat cell linesRatAorta, thoracic, smooth muscleDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
RBL-2H3 Cells305194Rat cell linesRatPeripheral bloodRat leukemiaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
AH-130 FN Cells500451Rat cell linesRatLiverHepatocellular carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
NRK-52E Cells305196Rat cell linesRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
WB-F344 Cells305201Rat cell linesRatLiverEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RG2 Cells300649Rat cell linesRatBrainRat malignant gliomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
RH-35 Cells305210Rat cell linesRatLiverRat hepatocellular carcinomaHams F12, w: 1.0 mM stable Glutamine, w: 1.0 mM Sodium pyruvate, w: 1.1 g/L NaHCO3 (Cytion article number 820600a)
RBL-1 Cells500389Rat cell linesRatPeripheral bloodLeukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
O-342 Cells500305Rat cell linesRatOvaryAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HBZY-1 Cells305206Rat cell linesRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
DSL-6B-C2 Cells500167Rat cell linesRatPancreasCarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SHZ-88 Cells305209Rat cell linesRatMastocarcincmaAdenocarcinoma of the rat mammary glandRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CC531 Cells500387Rat cell linesRatColonAdenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BRL Cells305193Rat cell linesRatLiverEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
CLS-ACI-1 Cells500459Rat cell linesRatBreastAdenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
AH-130 Cells500412Rat cell linesRatLiverHepatocellular carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Zajdela-Hepatoma Cells500306Rat cell linesRatLiverHepatocellular carcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
C6 Cells500142Rat cell linesRatBrainGliomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MH-TC-5123 Cells500287Rat cell linesRatLiverHepatocellular carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
PC 61 5.3 Cells305001Rat cell lines | Mouse cell linesAnimal cellsSpleenDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-Nup93-mEGFP #79 Cells300655Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-2xZFN-Smc4-mEGFP Clone 82-68 Cells301576Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-CAP-D3-mEGFP no.16 Cells301573Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-mEGFP-Nup214 #2-12 Cells300661Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-NUP205-mEGFP no.81 Cells301574Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-mEGFP-Nup358 no.97 Cells301575Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-NUP96-mMaple clone no.16 Cells300461Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
HK EB3-EGFP Cells300668Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK EGFP-LaminB1/H2B-mCherry Cells300919Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-CAP-H-mEGFP no.86 Cells301568Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-2xZFN-mEGFP-Nup107 Cells300676Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK EGFP-LaminA/H2B-mCherry Cells300921Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-mEGFP-Nup153 #90 Cells300656Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NRK-IBB-DiHcRed1 Cells500671Reporter-labeled cellsRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK EGFP-H2B Cells300673Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-NUP96-SNAP clone no.33 Cells300444Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
HK-CRISPR-mEGFP-RanBP2/Nup358 #97 Cells300660Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NRK-Pom121-EGFP3 Cells500669Reporter-labeled cellsRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NRK-EGFP2-Nup50 Cells500726Reporter-labeled cellsRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-TPR-SNAP #2-F01 Cells300667Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
HK-2xCRISPR-CAP-D2-mEGFP no.272-78 Cells301572Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NRK-4xlambdaN22-3xmEGFP-M9 Cells500672Reporter-labeled cellsRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-CAP-H2-mEGFP no.67 Cells301569Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-Nup188-mEGFP #11-092 Cells300657Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-SNAPf-Nup358/RanBP2 #721 Cells300663Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
HK Mad2-LAP/H2B-mCherry Cells300920Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK EGFP-alpha-tubulin/H2B-mCherry Cells300670Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-NUP96-Halo clone no.252 Cells300448Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
HK-CRISPR-mEGFP-Seh1 #76-2 Cells300669Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-ZFN-AURKB-mEGFP Cells300173Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-NUP96-mEGFP clone no.195 Cells300174Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
U2OS-ZFN-SNAP-Nup107 no.294 Cells300294Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
NS3-CMPK-hLBR1TM-mEGFP Cells300986Reporter-labeled cellsHumanUterusAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NRK-EGFP-H2B Cells500724Reporter-labeled cellsRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-Nup62-mEGFP #199 Cells300659Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-ZFN-AURKB-mEGFP/ZFN-INCENP-mCherry Cells300270Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK EGFP-Kleisin-beta Cells300674Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK-CRISPR-Pom121-mCherry #32 Cells300658Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HK EGFP-Cap-D2 Cells300675Reporter-labeled cellsHumanCervixCarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-SNAPf-SEH1 #238 Cells300664Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
HK-CRISPR-Tpr-mEGFP #171 Cells300662Reporter-labeled cellsHumanEndocervixAdenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
U2OS-CRISPR-SNAPf-Nup133 #80 Cells300666Reporter-labeled cellsHumanBoneOsteosarcomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
NRK-EGFP3-Seh1 Cells500731Reporter-labeled cellsRatKidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
PM-LGSOC-01 Cells300305Reproductive system cancer cell linesHumanOvaryLow grade-serous ovarian carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
MS751 Cells305115Reproductive system cancer cell linesHumanCervixHuman papillomavirus-related cervical squamous cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Caov-3 Cells300319Reproductive system cancer cell linesHumanOvaryHigh grade ovarian serous adenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NCCIT Cells305080Reproductive system cancer cell linesHumanAnterior mediastinal mixed germ cell tumorTesticular embryonal carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
BEWO Cells300123Reproductive system cancer cell linesHumanPlacentaChoriocarcinomaHams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
CERV-186 Cells300290Reproductive system cancer cell linesHumanCervixSquamous cell carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
RL95-2 Cells305062Reproductive system cancer cell linesHumanUterus, endometriumEndometrial adenosquamous carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
SK-UT-1B Cells300406Reproductive system cancer cell linesHumanUterineMixed mesodermal tumor. Consistent with leiomyosarcoma (grade III)EMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HEC-1-A Cells305077Reproductive system cancer cell linesHumanUterus, endometriumEndometrial adenocarcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
ME-180 Cells300196Reproductive system cancer cell linesHumanUterus, CervixEpidermoid CarcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
SK-UT-1 Cells300455Reproductive system cancer cell linesHumanUterineMixed mesodermal tumor, consistent with leiomyosarcoma (grade III)EMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Anglne Cells305144Reproductive system cancer cell linesHumanOvaryOvarian carcinoma
HEC-1-B Cells305095Reproductive system cancer cell linesHumanUterus, endometriumEndometrial adenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HeLa Cells300194Reproductive system cancer cell linesHumanCervixAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
A2780 Cells300491Reproductive system cancer cell linesHumanOvaryRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
C-33 A Cells305072Reproductive system cancer cell linesHumanCervixSquamous cell carcinoma of the cervix uteriEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SK-OV-3 Cells300342Reproductive system cancer cell linesHumanOvarySerous cystadenocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
OVCAR3 Cells300307Reproductive system cancer cell linesHumanOvaryHigh grade ovarian serous adenocarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
AN3 Ca Cells300119Reproductive system cancer cell linesHumanUterus, EndometriumAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Hey Cells305017Reproductive system cancer cell linesHumanOvaryHigh grade ovarian serous adenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CERV-196 Cells300291Reproductive system cancer cell linesHumanCervixSquamous cell carcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
OAW-42 Cells300304Reproductive system cancer cell linesHumanOvaryCystadenocarcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
JAR Cells300221Reproductive system cancer cell linesHumanPlacentaChoriocarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
Hela 229 Cells305056Reproductive system cancer cell linesHumanCervixHuman papillomavirus-related endocervical adenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
KB Cells300446Reproductive system cancer cell linesHumanEndocervixAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HeLa S3 Cells300384Reproductive system cancer cell linesHumanCervixAdenocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
JEG-3 Cells300222Reproductive system cancer cell linesHumanPlacentaChoriocarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SiHa Cells305023Reproductive system cancer cell linesHumanCervixHuman papillomavirus-related cervical squamous cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
CaSki Cells300145Reproductive system cancer cell linesHumanCervixCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MLTC-1 Cells305175Reproductive system cancer cell linesMouseTestisMouse Leydig cell tumorRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
KLE Cells305051Reproductive system cancer cell linesHumanUterus, EndometriumEndometrial adenocarcinomDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
PA-1 Cells300402Reproductive system cancer cell linesHumanOvaryOvarian mixed germ cell tumorEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
ES-2 Cells305038Reproductive system cancer cell linesHumanOvaryOvarian clear cell adenocarcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
SK-LMS-1 Cells300125Reproductive system cancer cell linesHumanVulvarLeiomyosarcomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
CERV-215 Cells300292Reproductive system cancer cell linesHumanCervixCarcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
M14 Cells302163Skin cancer cell linesHumanSkinAmelanotic melanomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
ARPE-19 Cells305025Skin cancer cell linesHumanEye, retinal pigmented epithelium, retinaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
HS-695T Cells300211Skin cancer cell linesHumanSkinAmelanotic melanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MeWo Cells300285Skin cancer cell linesHumanSkinCutaneous melanomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HMY-1 Cells305145Skin cancer cell linesHumanSkinMelanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
CCD-1095Sk Cells300642Skin cancer cell linesHumanSkinDuctal carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
MEG-01 Cells300482Skin cancer cell linesHumanBone marrowChronic myeloid leukemiaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MEL-CLS-1 Cells300175Skin cancer cell linesHumanSkinAmelanotic melanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
NIS-G Cells300303Skin cancer cell linesHumanSkinMelanomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MEL-JUSO Cells300282Skin cancer cell linesHumanSkinCutaneous melanomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
A431 Cells300112Skin cancer cell linesHumanEpidermoidSquamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SCL I Cells300496Skin cancer cell linesHumanFace, skinSquamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SK-MEL-28 Cells300337Skin cancer cell linesHumanSkinCutaneous melanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
IGR-1 Cells300219Skin cancer cell linesHumanSkinMalignant melanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
A375 Cells300110Skin cancer cell linesHumanSkinMelanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SK-MEL-5 Cells300157Skin cancer cell linesHumanSkinMelanomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
Colo-38 Cells300151Skin cancer cell linesHumanSkinAmelanotic melanomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HS1-CLS Cells300212Skin cancer cell linesHumanSkinSarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
WS1-CLS Cells300378Skin cancer cell linesHumanSkinSarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MEL-CLS-3 Cells300293Skin cancer cell linesHumanSkinAmelanotic melanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SK-MEL-29.1 Cells300429Skin cancer cell linesHumanSkinMelanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SK-MEL-1 Cells300424Skin cancer cell linesHumanSkinMelanomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
G361 Cells302157Skin cancer cell linesHumanSkinMelanomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
A2058 Cells305046Skin cancer cell linesHumanSkinAmelanotic melanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MEL-CLS-2 Cells300283Skin cancer cell linesHumanHuman xenograftMelanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
MML-1 Cells300288Skin cancer cell linesHumanSkinMelanomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
MEL-CLS-4 Cells300128Skin cancer cell linesHumanSkinMelanosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SCL II Cells300497Skin cancer cell linesHumanSkin, FaceSquamous cell carcinomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
A875 Cells305099Skin cancer cell linesHumanSkinMelanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SK-MEL-2 Cells300423Skin cancer cell lines | Human cellsHumanSkinMelanomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
TE-671 Cells300355Soft tissue cancer cell linesHumanMuscleRhabdomyosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SW-872 Cells300405Soft tissue cancer cell linesHumanConnective tissueLiposarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SW-684 Cells300422Soft tissue cancer cell linesHumanConnective tissueFibrosarcomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
A204 Cells300109Soft tissue cancer cell linesHumanMuscleRhabdomyosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
SW-982 Cells300404Soft tissue cancer cell linesHumanSynovialBiphasic synovial sarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
S-117 Cells300329Soft tissue cancer cell linesHumanThyroideaSarcomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RD Cells300401Soft tissue cancer cell linesHumanEmbryonicRhabdomyosarcomaDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
HT-1080 Cells300216Soft tissue cancer cell linesHumanFibrosarcomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
NCI-H295R Cell Growth Medium820402Special Cell Culture Media
Endothelial Cell Growth Medium820731Special Cell Culture Media
Human Mesenchymal Stem Cells - Bone Marrow (HMSC-BM)300665Stem CellsHumanBone MarrowAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Mesenchymal Stem Cells - Amnion300644Stem CellsHumanAmnionAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Mesenchymal Stem Cells - Chorion Villi300646Stem CellsHumanChorion VilliAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Mesenchymal Stem Cells - Umbilical Cord - Artery300648Stem CellsHumanUmbilical Cord - ArteryAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Mesenchymal Stem Cells - Endometrium300647Stem CellsHumanEndometriumAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Mesenchymal Stem Cells - Whartons Jelly (HMSC-WJ)300685Stem CellsHumanUmbilical Cord - Whartons JellyAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Mesenchymal Stem Cells - Adipose Tissue300645Stem CellsHumanAdipose TissueAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
Human Dental Follicle stem Cells (hDFSC) Cells300701Stem Cells | Oral cellsHumanDentalAlpha MEM, w: 2.0 mM stable Glutamine, w/o: Ribonucleosides, w/o: Deoxyribonucleosides, w: 1.0 mM Sodium pyruvate, w: 2.2g/L NaHCO3
HTR-8/SVneo Cells305221Transformed cell linesHumanTrophoblastRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
RWPE-1 Cells305217Transformed cell linesHumanProstateK-SFM (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
WT100 Cells302139Transformed cell linesHumanPeripheral bloodRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HMEC-1 Cells304064Transformed cell linesHumanSkinMCDB131 (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
HEK293 EBNA Cells300264Transformed cell linesHumanEmbryonic kidneyDMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
BEAS-2B Cells300311Transformed cell linesHumanLung, BronchusAirway Epithelial Cell Basal Medium (PromoCell GmbH)
HK Cells300204Transformed cell linesHumanOral cavity, tonsilEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HEK293A Cells305070Transformed cell lines | Kidney cancer cell lines | Human cellsHumanEmbryonic kidneyEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
SW780 Cells305098Urinary bladder cancer cell linesHumanUrinary bladderBladder carcinomaLeibovitzs L-15, w: 2.0 mM L-Glutamine, 0.55 g/L NaHCO3 (We do not supply this product| please consider other suppliers. Please let us know if you need further assistance)
SV-HUC-1 Cells305075Urinary bladder cancer cell linesHumanUreter, uroepitheliumHams F12K Medium, w: 2.0 mM L-Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.5 g/L NaHCO3 (Cytion article number 820608a)
SCaBER Cells305111Urinary bladder cancer cell linesHumanUrinary bladderBladder squamous cell carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
TCCSUP Cells305073Urinary bladder cancer cell linesHumanUrinary bladderBladder carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RT-112 Cells300324Urinary bladder cancer cell linesHumanBladderCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
J82 Cells305055Urinary bladder cancer cell linesHumanUrinary bladderBladder carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
HT-1376 Cells305100Urinary bladder cancer cell linesHumanUrinary bladderBladder carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
RT-4 Cells300326Urinary bladder cancer cell linesHumanBladderTransitional cell papillomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
5637 Cells300105Urinary bladder cancer cell linesHumanBladderCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
HB-CLS-1 Cells300190Urinary bladder cancer cell linesHumanBladderCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
UM-UC-3 Cells305074Urinary bladder cancer cell linesHumanUrinary bladderBladder carcinomaEMEM, w: 2 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: EBSS, w: 1 mM Sodium pyruvate, w: NEAA (Cytion article number 820100c)
ECV-304 Cells300452Urinary bladder cancer cell linesHumanBladderCarcinomaMedium 199, w: 2.7 mM stable Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820101a)
HB-CLS-2 Cells300191Urinary bladder cancer cell linesHumanBladderCarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
T24 Cells300352Urinary bladder cancer cell linesHumanBladderCarcinomaDMEM:Hams F12, w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
RT-112-D21 Cells300325Urinary bladder cancer cell linesHumanBladderCarcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
CLS-439 Cells300150Urinary bladder cancer cell linesHumanBladderCarcinomaMcCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a)
EJ-28 Cells300172Urinary bladder cancer cell linesHumanBladderBladder carcinomaRPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)